NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis $4.26 -0.12 (-2.74%) Closing price 04:00 PM EasternExtended Trading$4.25 -0.01 (-0.33%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Outset Medical Stock (NASDAQ:OM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Outset Medical alerts:Sign Up Key Stats Today's Range$4.15▼$4.3450-Day Range$3.16▼$4.7752-Week Range$3.00▼$21.98Volume93,540 shsAverage Volume179,565 shsMarket Capitalization$78.98 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingHold Company Overview Outset Medical is a medical technology company specializing in innovations for renal care. The company’s flagship offering, the Tablo Hemodialysis System, is designed to streamline and simplify dialysis treatment across acute and outpatient settings. By integrating water purification, dialysate production, and treatment monitoring into a single device, Tablo aims to reduce the complexity and logistical burden traditionally associated with hemodialysis therapy. Tablo’s modular design allows for rapid setup and flexible deployment in hospitals, clinics, long‐term care facilities and emergency response scenarios. The system’s intuitive touchscreen interface and automated processes enable clinicians and nursing staff to focus more on patient care and less on equipment management. Remote connectivity features facilitate data sharing, allowing care teams to monitor treatment parameters, troubleshoot issues and optimize protocols in real time. Founded in 2010 and headquartered in San Jose, California, Outset Medical secured FDA clearance for the Tablo system in 2017 and received CE mark approval for distribution in Europe shortly thereafter. Since its initial public offering in 2019, the company has expanded its geographic footprint to include markets across North America, Western Europe and the Asia-Pacific region. Strategic partnerships and distribution agreements have further enabled the rollout of Tablo in a variety of clinical environments, from large hospital networks to smaller dialysis centers. Under the leadership of CEO Leslie Trigg, Outset Medical continues to invest in research and development aimed at enhancing treatment efficiency, patient safety and overall care quality. The company’s mission centers on transforming the delivery of dialysis by making therapy more accessible, adaptable and patient-centric, while driving down the total cost of care through innovative technology solutions.AI Generated. May Contain Errors. Read More Outset Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreOM MarketRank™: Outset Medical scored higher than 45% of companies evaluated by MarketBeat, and ranked 589th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingOutset Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialOutset Medical has a consensus price target of $10.00, representing about 134.7% upside from its current price of $4.26.Amount of Analyst CoverageOutset Medical has only been the subject of 2 research reports in the past 90 days.Read more about Outset Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($3.82) to ($3.09) per share.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Outset Medical's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.12% of the float of Outset Medical has been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 15.43, which indicates bearish sentiment.Change versus previous monthShort interest in Outset Medical has recently decreased by 3.74%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.18 News SentimentOutset Medical has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Outset Medical this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $28,360.00 in company stock.Percentage Held by Insiders2.50% of the stock of Outset Medical is held by insiders.Percentage Held by InstitutionsOutset Medical has minimal institutional ownership at this time.Read more about Outset Medical's insider trading history. Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OM Stock News HeadlinesOutset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)4 hours ago | globenewswire.comInsider Selling: Outset Medical (NASDAQ:OM) CEO Sells 3,445 Shares of StockMay 20 at 7:06 AM | insidertrades.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 21 at 1:00 AM | Banyan Hill Publishing (Ad)Outset Medical (OM) price target decreased by 14.81% to 7.82May 14, 2026 | msn.comOutset Medical (OM) Receives a Hold from RBC CapitalMay 14, 2026 | theglobeandmail.comOutset Medical (OM) Q4 2025 Earnings TranscriptMay 9, 2026 | finance.yahoo.comOutset Medical, Inc. (OM) Q1 2026 Earnings Call TranscriptMay 9, 2026 | seekingalpha.comOutset Medical Bets on Margin Gains and Next-Gen TableauMay 8, 2026 | tipranks.comSee More Headlines OM Stock Analysis - Frequently Asked Questions How have OM shares performed this year? Outset Medical's stock was trading at $3.71 on January 1st, 2026. Since then, OM stock has increased by 14.8% and is now trading at $4.26. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) issued its quarterly earnings results on Thursday, May, 7th. The company reported ($0.83) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.79) by $0.04. The company earned $27.86 million during the quarter, compared to the consensus estimate of $28.90 million. Outset Medical had a negative net margin of 63.65% and a negative trailing twelve-month return on equity of 56.13%. Read the conference call transcript. When did Outset Medical's stock split? Outset Medical's stock reverse split on the morning of Thursday, March 20th 2025.The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an initial public offering on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Top institutional shareholders of Outset Medical include BML Capital Management LLC (10.27%), Assenagon Asset Management S.A. (2.75%), Renaissance Technologies LLC (1.20%) and Dimensional Fund Advisors LP (0.61%). Insiders that own company stock include Leslie Trigg, Marc Nash, John L Brottem, Steven S Williamson, Jean-Olivier Racine, Nabeel Ahmed and D Keith Grossman. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Outset Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and Company Calendar Last Earnings5/07/2026Today5/21/2026AGM 20266/04/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 OM's financial health is in the Red zone, according to TradeSmith. OM has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:OM CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees520Year Founded2003Price Target and Rating Average Price Target for Outset Medical$10.00 High Price Target$15.00 Low Price Target$7.00 Potential Upside/Downside+134.7%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($4.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.65 million Net Margins-63.65% Pretax Margin-62.96% Return on Equity-56.13% Return on Assets-27.45% Debt Debt-to-Equity Ratio0.87 Current Ratio6.29 Quick Ratio4.97 Sales & Book Value Annual Sales$119.48 million Price / Sales0.66 Cash FlowN/A Price / Cash FlowN/A Book Value$6.03 per share Price / Book0.71Miscellaneous Outstanding Shares18,540,000Free Float18,074,000Market Cap$78.98 million OptionableNot Optionable Beta1.92 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:OM) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
